Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001640334-19-000350
Filing Date
2019-03-04
Accepted
2019-03-04 17:25:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G toucan_sc13g.htm SC 13G 46075
  Complete submission text file 0001640334-19-000350.txt   47583
Mailing Address 4800 MONTGOMERY LANE, SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE, SUITE 800 BETHESDA MD 20814 240-497-4060
Toucan Capital Fund III, L.P. (Filed by) CIK: 0001626842 (see all company filings)

EIN.: 451742900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Subject) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90859 | Film No.: 19655211
SIC: 2836 Biological Products, (No Diagnostic Substances)